Clinical Measure Baseline 6 Months Change* P A1C, mean (SD) (N=313) 8.21(1.0) 7.45 (1.22) -0.76(1.14) <0.01 A1C, % (N=313) ≤6.5%**   22.0     <7.0%**   37.1     <7.5% 19.8 58.5 38.7 <0.01           Weight (kg), mean (SD) (N=299) 100.7(19.0) 97.8(18.6) -2.9 (5.4) <0.01       -0.03 (0.1)*** <0.01 Lipids mg/dl         Cholesterol, mean (SD) (N=148) 166.2(42.3) 156.5(39.2) -9.6(38.4) <0.01 HDL, mean (SD) (N=145) 42.8(11.8) 42.8(12.6) 0.04(6.2) 0.94           Blood pressure mm Hg (N=297)         SBP, mean (SD) 132.0(16.0) 129.2(15.4) -2.9(17.4) <0.01 DBP, mean (SD) 73.4(8.9) 72.6(9.7) -0.8(9.6) 0.17

Table 2: Liraglutide clinical measures at baseline and 6 months, *Changes shown are absolute (6 month value minus baseline value) unless otherwise noted. **Patients were included in the study only if baseline A1C was greater than 7%. ***Relative change (=absolute change divided by baseline value). Note: Data expressed as mean (standard deviation) unless otherwise noted. HDL, high density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure.